Tocilizumab is an IL-6 receptor antagonist used in rheumatoid arthritis treatment.
It blocks IL-6 signaling, reducing inflammation and autoimmune damage.
TNF-alpha inhibitors are common for RA management, but IL-6 inhibition provides an alternative therapeutic pathway.